Skip to main content
Journal cover image

Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury.

Publication ,  Journal Article
Vuppalanchi, R; Bonkovsky, HL; Ahmad, J; Barnhart, H; Durazo, F; Fontana, RJ; Gu, J; Khan, I; Kleiner, DE; Koh, C; Rockey, DC; Phillips, EJ ...
Published in: Clin Gastroenterol Hepatol
June 2022

BACKGROUND & AIMS: Garcinia cambogia, either alone or with green tea, is commonly promoted for weight loss. Sporadic cases of liver failure from G cambogia have been reported, but its role in liver injury is controversial. METHODS: Among 1418 patients enrolled in the Drug-Induced Liver Injury Network (DILIN) from 2004 to 2018, we identified 22 cases (adjudicated with high confidence) of liver injury from G cambogia either alone (n = 5) or in combination with green tea (n = 16) or Ashwagandha (n = 1). Control groups consisted of 57 patients with liver injury from herbal and dietary supplements (HDS) containing green tea without G cambogia and 103 patients from other HDS. RESULTS: Patients who took G cambogia were between 17 and 54 years, with liver injury arising 13-223 days (median = 51) after the start. One patient died, one required liver transplantation, and 91% were hospitalized. The liver injury was hepatocellular with jaundice. Although the peak values of aminotransferases were significantly higher (2001 ± 1386 U/L) in G cambogia group (P < .018), the median time for improvement in total bilirubin was significantly lower compared with the control groups (10 vs 17 and 13 days; P = .03). The presence of HLA-B∗35:01 allele was significantly higher in the G cambogia containing HDS (55%) compared with patients because of other HDS (19%) (P = .002) and those with acute liver injury from conventional drugs (12%) (P = 2.55 × 10-6). CONCLUSIONS: The liver injury caused by G cambogia and green tea is clinically indistinguishable. The possible association with HLA-B∗35:01 allele suggests an immune-mediated mechanism of injury. CLINICAL TRIALS: gov number: NCT00345930.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

June 2022

Volume

20

Issue

6

Start / End Page

e1416 / e1425

Location

United States

Related Subject Headings

  • Tea
  • Humans
  • HLA-B Antigens
  • Gastroenterology & Hepatology
  • Garcinia cambogia
  • Dietary Supplements
  • Chemical and Drug Induced Liver Injury
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vuppalanchi, R., Bonkovsky, H. L., Ahmad, J., Barnhart, H., Durazo, F., Fontana, R. J., … Drug-Induced Liver Injury Network, . (2022). Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. Clin Gastroenterol Hepatol, 20(6), e1416–e1425. https://doi.org/10.1016/j.cgh.2021.08.015
Vuppalanchi, Raj, Herbert L. Bonkovsky, Jawad Ahmad, Huiman Barnhart, Francisco Durazo, Robert J. Fontana, Jiezhun Gu, et al. “Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury.Clin Gastroenterol Hepatol 20, no. 6 (June 2022): e1416–25. https://doi.org/10.1016/j.cgh.2021.08.015.
Vuppalanchi R, Bonkovsky HL, Ahmad J, Barnhart H, Durazo F, Fontana RJ, et al. Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1416–25.
Vuppalanchi, Raj, et al. “Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury.Clin Gastroenterol Hepatol, vol. 20, no. 6, June 2022, pp. e1416–25. Pubmed, doi:10.1016/j.cgh.2021.08.015.
Vuppalanchi R, Bonkovsky HL, Ahmad J, Barnhart H, Durazo F, Fontana RJ, Gu J, Khan I, Kleiner DE, Koh C, Rockey DC, Phillips EJ, Li Y-J, Serrano J, Stolz A, Tillmann HL, Seeff LB, Hoofnagle JH, Navarro VJ, Drug-Induced Liver Injury Network. Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. Clin Gastroenterol Hepatol. 2022 Jun;20(6):e1416–e1425.
Journal cover image

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

June 2022

Volume

20

Issue

6

Start / End Page

e1416 / e1425

Location

United States

Related Subject Headings

  • Tea
  • Humans
  • HLA-B Antigens
  • Gastroenterology & Hepatology
  • Garcinia cambogia
  • Dietary Supplements
  • Chemical and Drug Induced Liver Injury
  • 3202 Clinical sciences
  • 1103 Clinical Sciences